Gene: MON1B
Official Full Name: MON1 homolog B, secretory trafficking associatedprovided by HGNC
Gene Summary: Involved in early viral transcription and late viral transcription. Located in cytoplasm. Part of Mon1-Ccz1 complex. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO30212 | MON1B Knockout cell line (HeLa) | Human | MON1B | 1:3~1:6 | Negative | Online Inquiry |
KO30213 | MON1B Knockout cell line (HCT 116) | Human | MON1B | 1:2~1:4 | Negative | Online Inquiry |
KO30214 | MON1B Knockout cell line (HEK293) | Human | MON1B | 1:3~1:6 | Negative | Online Inquiry |
KO30215 | MON1B Knockout cell line (A549) | Human | MON1B | 1:3~1:4 | Negative | Online Inquiry |
MON1B Gene Knockout Cell Lines are genetically modified cell lines specifically designed to lack the functional MON1B gene, which is implicated in various cellular processes including lysosomal function and intracellular trafficking. By introducing targeted gene editing techniques, such as CRISPR/Cas9, these cell lines allow researchers to study the specific role of MON1B in cellular physiology and pathology, facilitating a better understanding of diseases associated with dysregulated MON1B activity.
The key function of MON1B Gene Knockout Cell Lines lies in their ability to provide insight into the mechanisms through which MON1B contributes to cellular function. By observing the phenotypic and biochemical changes that occur in the absence of MON1B, researchers can gain valuable information about the gene’s role in processes like endocytosis, autophagy, and immune response. This sheds light not only on basic biological functions but also on potential therapeutic targets for diseases linked to MON1B dysregulation.
The scientific importance of these cell lines is evident in both research and clinical settings, serving as powerful tools for drug discovery, toxicological studies, and the elucidation of disease pathways. Their application extends to the study of neurodegenerative diseases, cancer, and metabolic disorders, where understanding the role of MON1B can guide novel treatment strategies.
Compared to alternative gene knockout systems, MON1B Gene Knockout Cell Lines offer increased specificity and reliability, ensuring that researchers can be confident in the results obtained. Furthermore, their ease of use and compatibility with various assay types make them an attractive option for laboratories seeking to streamline their experimental workflow.
For researchers and clinicians alike, the value of MON1B Gene Knockout Cell Lines becomes evident through their potential to accelerate research findings and contribute to the development of targeted therapies. Decades of experience in genetic engineering and commitment to quality ensure that our product meets rigorous research standards, providing a reliable resource for advancing scientific knowledge and improving health outcomes.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.